BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22524660)

  • 21. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H; Shimizu S; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
    Na II; Rho JK; Choi YJ; Kim CH; Park JH; Koh JS; Ryoo BY; Yang SH; Lee JC
    Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan.
    Lee CN; Yu MC; Bai KJ; Chang JH; Fang CL; Hsu HL; Huang BS; Lu PC; Liu HE
    Lung Cancer; 2009 Apr; 64(1):9-12. PubMed ID: 18706736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
    Sonobe M; Nakagawa M; Takenaka K; Katakura H; Adachi M; Yanagihara K; Otake Y; Wada H; Tanaka F
    J Surg Oncol; 2007 Jan; 95(1):63-9. PubMed ID: 17192868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
    Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
    Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer.
    Suzuki M; Shigematsu H; Nakajima T; Kubo R; Motohashi S; Sekine Y; Shibuya K; Iizasa T; Hiroshima K; Nakatani Y; Gazdar AF; Fujisawa T
    Clin Cancer Res; 2007 Oct; 13(20):6087-92. PubMed ID: 17947472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin D as a potential prognostic marker for lung adenocarcinoma.
    Mimae T; Tsuta K; Maeshima AM; Okada M; Asamura H; Kondo T; Tsuda H
    Pathol Res Pract; 2012 Sep; 208(9):534-40. PubMed ID: 22824147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
    Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
    Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of hypoxia-inducible factor-1α in epidermal growth factor receptor-negative non-small cell lung cancer.
    Park S; Ha SY; Cho HY; Chung DH; Kim NR; Hong J; Cho EK
    Lung Cancer; 2011 Apr; 72(1):100-7. PubMed ID: 20822827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGFR nuclear import in gallbladder carcinoma: nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact.
    Li CF; Fang FM; Wang JM; Tzeng CC; Tai HC; Wei YC; Li SH; Lee YT; Wang YH; Yu SC; Shiue YL; Chu PY; Wang WL; Chen LT; Huang HY
    Ann Surg Oncol; 2012 Feb; 19(2):443-54. PubMed ID: 21761100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
    Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
    Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of lung cancer in women: importance of hormonal and growth factors.
    Rouquette I; Lauwers-Cances V; Allera C; Brouchet L; Milia J; Nicaise Y; Laurent J; Delisle MB; Favre G; Didier A; Mazières J
    Lung Cancer; 2012 Jun; 76(3):280-5. PubMed ID: 22197614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
    Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
    Clin Lung Cancer; 2017 Jul; 18(4):e273-e281. PubMed ID: 28065467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of epidermal growth factor receptor (EGFR), platelet growth factor receptor (PGFR) and insulin growth factor-1 receptor (IGF-1R) on lung cancer cell].
    Liu S; Zhang B; Zhang S
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):733-4. PubMed ID: 11480076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Ret finger protein correlates with outcomes in endometrial cancer.
    Tsukamoto H; Kato T; Enomoto A; Nakamura N; Shimono Y; Jijiwa M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
    Cancer Sci; 2009 Oct; 100(10):1895-901. PubMed ID: 19650860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different nuclear/cytoplasmic distributions of RET finger protein in different cell types.
    Tezel G; Nagasaka T; Iwahashi N; Asai N; Iwashita T; Sakata K; Takahashi M
    Pathol Int; 1999 Oct; 49(10):881-6. PubMed ID: 10571821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The expression of erbB/HER family in lung cancer].
    Deng Z; Ge D; Zhang D; Tan Y; Bai C; Xu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Apr; 25(4):207-9. PubMed ID: 12133326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.